FMP

FMP

Enter

VTVT - vTv Therapeutics Inc...

photo-url-https://images.financialmodelingprep.com/symbol/VTVT.png

vTv Therapeutics Inc.

VTVT

NASDAQ

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approach to activating the Nrf2 pathway for the treatment of chronic diseases associated with oxidative stress; azeliragon, a RAGE antagonist for inflammatory lung diseases, including severe COVID-19, as well as for pancreatic and breast cancers; and HPP971, an Nrf2 activator for renal diseases through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; and Novo Nordisk A/S. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated.

13.2 USD

-0.54 (-4.09%)

Balance Sheet

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Total Cash

1.78M

5.75M

13.41M

12.13M

9.45M

-

-

-

-

-

Total Cash %

64.29

89.6

334.96

600.89

100

90.78

90.78

90.78

90.78

Receivables

5k

158k

57k

12.42M

102k

-

-

-

-

-

Receivables %

0.18

2.46

1.42

615.26

100

40.81

40.81

40.81

40.81

Inventories

250k

371k

100k

15k

-

-

-

-

-

-

Inventories %

9.04

5.78

2.5

0.74

100

23.61

23.61

23.61

23.61

Payable

2.23M

1.93M

1.88M

2.46M

4.08M

-

-

-

-

-

Payable %

80.75

30.01

46.84

121.95

100

71.52

71.52

71.52

71.52

Cap Ex

-70k

-

-

-21k

-

-

-

-

-

-

Cap Ex %

-2.53

-

-

-1.04

100

-0.71

-0.71

-0.71

-0.71

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep